Macrocephalic mental retardation associated with a novel C-terminal MECP2 frameshift deletion.

PubWeight™: 1.39‹?› | Rank: Top 5%

🔗 View Article (PMID 15558314)

Published in Eur J Pediatr on November 19, 2004

Authors

Konrad Oexle1, Barbara Thamm-Mücke, Thomas Mayer, Sigrid Tinschert

Author Affiliations

1: Institut für Klinische Genetik, Medizinische Fakultät Carl Gustav Carus, Technische Universität Dresden, Fetscherstrasse 74, 01307 Dresden, Germany. konrad.oexle@mailbox.tu-dresden.de

Articles cited by this

Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat Genet (1999) 22.84

Rett syndrome and beyond: recurrent spontaneous and familial MECP2 mutations at CpG hotspots. Am J Hum Genet (1999) 2.42

A previously unidentified MECP2 open reading frame defines a new protein isoform relevant to Rett syndrome. Nat Genet (2004) 1.88

Head circumference reference data: birth to 18 years. Pediatrics (1987) 1.75

Long-read sequence analysis of the MECP2 gene in Rett syndrome patients: correlation of disease severity with mutation type and location. Hum Mol Genet (2000) 1.61

A mutation hot spot for nonspecific X-linked mental retardation in the MECP2 gene causes the PPM-X syndrome. Am J Hum Genet (2002) 1.18

A severely affected male born into a Rett syndrome kindred supports X-linked inheritance and allows extension of the exclusion map. Am J Hum Genet (1998) 1.18

Effects of MECP2 mutation type, location and X-inactivation in modulating Rett syndrome phenotype. Am J Med Genet A (2003) 1.13

Rett syndrome: the complex nature of a monogenic disease. J Mol Med (Berl) (2003) 1.10

Head growth in Rett syndrome. Brain Dev (2001) 1.04

Mutation analysis of the methyl-CpG-binding protein 2 gene (MECP2) in Rett patients with preserved speech. Brain Dev (2001) 0.95

The spectrum of phenotypes in females with Rett Syndrome. Brain Dev (2003) 0.95

MECP2 mutations in Danish patients with Rett syndrome: high frequency of mutations but no consistent correlations with clinical severity or with the X chromosome inactivation pattern. Eur J Hum Genet (2001) 0.91

Screening of MECP2 coding sequence in patients with phenotypes of decreasing likelihood for Rett syndrome: a cohort of 171 cases. J Med Genet (2004) 0.88

Low frequency of MECP2 mutations in mentally retarded males. Eur J Hum Genet (2002) 0.83

Articles by these authors

Fusion of cells by flipped SNAREs. Science (2003) 2.60

Phacomatosis pigmentokeratotica is caused by a postzygotic HRAS mutation in a multipotent progenitor cell. J Invest Dermatol (2013) 2.31

Wnt signaling and Dupuytren's disease. N Engl J Med (2011) 2.02

Shprintzen-Goldberg syndrome: fourteen new patients and a clinical analysis. Am J Med Genet A (2005) 1.91

First human trial of FTY720, a novel immunomodulator, in stable renal transplant patients. J Am Soc Nephrol (2002) 1.71

Sequence characteristics of functional siRNAs. RNA (2005) 1.59

Mutations in bone morphogenetic protein receptor 1B cause brachydactyly type A2. Proc Natl Acad Sci U S A (2003) 1.52

Dyschromatosis universalis hereditaria: familial case and ultrastructural skin investigation. Am J Med Genet A (2004) 1.43

Increasing the yield in targeted next-generation sequencing by implicating CNV analysis, non-coding exons and the overall variant load: the example of retinal dystrophies. PLoS One (2013) 1.40

Mutations in the glycosylphosphatidylinositol gene PIGL cause CHIME syndrome. Am J Hum Genet (2012) 1.38

A misplaced lncRNA causes brachydactyly in humans. J Clin Invest (2012) 1.36

Screening 500 unselected neurofibromatosis 1 patients for deletions of the NF1 gene. Hum Mutat (2004) 1.34

Expanding the clinical spectrum associated with defects in CNTNAP2 and NRXN1. BMC Med Genet (2011) 1.24

Spectrum of mutations in PTPN11 and genotype-phenotype correlation in 96 patients with Noonan syndrome and five patients with cardio-facio-cutaneous syndrome. Eur J Hum Genet (2003) 1.23

A comprehensive molecular study on Coffin-Siris and Nicolaides-Baraitser syndromes identifies a broad molecular and clinical spectrum converging on altered chromatin remodeling. Hum Mol Genet (2013) 1.22

Novel mutations in BCOR in three patients with oculo-facio-cardio-dental syndrome, but none in Lenz microphthalmia syndrome. Eur J Hum Genet (2005) 1.19

Twenty-six novel EFNB1 mutations in familial and sporadic craniofrontonasal syndrome (CFNS). Hum Mutat (2005) 1.17

Two brothers with findings resembling congenital intrauterine infection-like syndrome (pseudo-TORCH syndrome). Am J Med Genet A (2003) 1.16

Mutations in NSD1 are responsible for Sotos syndrome, but are not a frequent finding in other overgrowth phenotypes. Eur J Hum Genet (2003) 1.14

A cis-regulatory site downregulates PTHLH in translocation t(8;12)(q13;p11.2) and leads to Brachydactyly Type E. Hum Mol Genet (2009) 1.13

Imaging seizure activity: a combined EEG/EMG-fMRI study in reading epilepsy. Epilepsia (2008) 1.12

Synthesis and target identification of hymenialdisine analogs. Chem Biol (2004) 1.05

Pharmacodynamics of single doses of the novel immunosuppressant FTY720 in stable renal transplant patients. Am J Transplant (2003) 1.04

Nuclear matrix protein-22: a prospective evaluation in a population at risk for bladder cancer. Results from the UroScreen study. BJU Int (2012) 1.04

Complete physical map and gene content of the human NF1 tumor suppressor region in human and mouse. Genes Chromosomes Cancer (2003) 1.02

Homozygous PMS2 germline mutations in two families with early-onset haematological malignancy, brain tumours, HNPCC-associated tumours, and signs of neurofibromatosis type 1. Eur J Hum Genet (2007) 1.00

Dissecting the molecular mechanisms in craniofrontonasal syndrome: differential mRNA expression of mutant EFNB1 and the cellular mosaic. Eur J Hum Genet (2007) 1.00

Seizure anticipation by patients with focal and generalized epilepsy: a multicentre assessment of premonitory symptoms. Epilepsy Res (2006) 0.95

Four unrelated patients with Lubs X-linked mental retardation syndrome and different Xq28 duplications. Am J Med Genet A (2010) 0.94

Restless legs syndrome: epidemiological and clinicogenetic study in a South Tyrolean population isolate. Mov Disord (2006) 0.94

Compound heterozygosity for two MSH6 mutations in a patient with early onset of HNPCC-associated cancers, but without hematological malignancy and brain tumor. Eur J Hum Genet (2006) 0.94

A homozygous mutation in the tight-junction protein JAM3 causes hemorrhagic destruction of the brain, subependymal calcification, and congenital cataracts. Am J Hum Genet (2010) 0.93

A novel germline KIT mutation (p.L576P) in a family presenting with juvenile onset of multiple gastrointestinal stromal tumors, skin hyperpigmentations, and esophageal stenosis. Am J Surg Pathol (2013) 0.92

Homozygous loss of CHRNA7 on chromosome 15q13.3 causes severe encephalopathy with seizures and hypotonia. Am J Med Genet A (2010) 0.92

«Interventional Neuroradiology: a neuroscience sub-specialty?». Interv Neuroradiol (2013) 0.90

Three novel mutations in the ANK membrane protein cause craniometaphyseal dysplasia with variable conductive hearing loss. Am J Med Genet A (2010) 0.90

Editorial: «Interventional Neuroradiology: a Neuroscience sub-specialty?». Interv Neuroradiol (2013) 0.89

A novel third type of recurrent NF1 microdeletion mediated by nonallelic homologous recombination between LRRC37B-containing low-copy repeats in 17q11.2. Hum Mutat (2010) 0.88

Czech dysplasia: report of a large family and further delineation of the phenotype. Am J Med Genet A (2008) 0.88

High-level somatic mosaicism of AKT1 c.49G>A mutation in skin scrapings from epidermal nevi enables non-invasive molecular diagnosis in patients with Proteus syndrome. Am J Med Genet A (2013) 0.88

Temporary aneurysm orifice balloon occlusion as an alternative to retrograde suction decompression for giant paraclinoid internal carotid artery aneurysms: technical note. Neurosurgery (2005) 0.88

Segmental neurofibromatosis. Dermatology (2002) 0.87

De novo microdeletions of chromosome 6q14.1-q14.3 and 6q12.1-q14.1 in two patients with intellectual disability - further delineation of the 6q14 microdeletion syndrome and review of the literature. Eur J Med Genet (2012) 0.85

Evaluation of intravenous voriconazole in patients with compromised renal function. BMC Infect Dis (2013) 0.85

Differential MSH2 promoter methylation in blood cells of Neurofibromatosis type 1 (NF1) patients. Eur J Hum Genet (2010) 0.85

Segmentally arranged basaloid follicular hamartomas with osseous, dental and cerebral anomalies: a distinct syndrome. Acta Derm Venereol (2008) 0.84

1.6Mb deletion in chromosome band 3q29 associated with eye abnormalities. Eur J Med Genet (2009) 0.83

Small reciprocal insertion detected by spectral karyotyping (SKY) and delimited by array-CGH analysis. Eur J Med Genet (2005) 0.83

Antenatal onset of cortical hyperostosis (Caffey disease): case report and review. Am J Med Genet A (2003) 0.83

Intronic mutations in the L1CAM gene may cause X-linked hydrocephalus by aberrant splicing. Hum Mutat (2004) 0.82

Monozygotic twins with neurofibromatosis type 1 (NF1) display differences in methylation of NF1 gene promoter elements, 5' untranslated region, exon and intron 1. Twin Res Hum Genet (2010) 0.82

Monitoring chemical reactions by using ion-channel-forming peptides. Chembiochem (2006) 0.81

A homozygous microdeletion within ADAMTSL4 in patients with isolated ectopia lentis: evidence of a founder mutation. Invest Ophthalmol Vis Sci (2011) 0.81

Extramedullary hematopoiesis occurring as a nasal polyp in a man with a myeloproliferative disorder. Ear Nose Throat J (2004) 0.81

Macrocerebellum: significance and pathogenic considerations. Cerebellum (2012) 0.81

Craniofacial hyperostoses in Proteus syndrome -- a case report. J Craniomaxillofac Surg (2004) 0.81

Reduced expression of hMSH2 protein is correlated to poor survival for soft tissue sarcoma patients. Cancer (2003) 0.80

MIA is a potential biomarker for tumour load in neurofibromatosis type 1. BMC Med (2011) 0.79

Problems in detecting mosaic DNA methylation in Angelman syndrome. Eur J Hum Genet (2003) 0.79

Analysis of mitochondrial DNA in discordant monozygotic twins with neurofibromatosis type 1. Twin Res Hum Genet (2007) 0.79

Concentrations of stiripentol in children and adults with epilepsy: the influence of dose, age, and comedication. Ther Drug Monit (2012) 0.78

Childhood overgrowth in patients with common NF1 microdeletions. Eur J Hum Genet (2005) 0.78

Severe intellectual disability, West syndrome, Dandy-Walker malformation, and syndactyly in a patient with partial tetrasomy 17q25.3. Am J Med Genet A (2013) 0.77

Detection of novel NF1 mutations and rapid mutation prescreening with Pyrosequencing. Electrophoresis (2007) 0.77

FTY720 and cyclosporine: evaluation for a pharmacokinetic interaction. Ann Pharmacother (2004) 0.76

Temperature dependence of ion mobility signals of halogenated compounds. Talanta (2012) 0.76

Focal epilepsy in glucose transporter type 1 (Glut1) defects: case reports and a review of literature. J Neurol (2014) 0.76

Pre- rather than co-application of vigabatrin increases the efficacy of tiagabine in hippocampal slices. Epilepsia (2002) 0.75

Substitution of anticonvulsant drugs. Ther Clin Risk Manag (2009) 0.75

Letter of apology. Stroke (2003) 0.75

Extraction of an embolus. N Engl J Med (2003) 0.75

Asymmetric, disproportionate craniofacial hyperostoses of mosaic pattern in a patient not meeting Proteus syndrome criteria. J Craniofac Surg (2011) 0.75

Bilateral anterior inferior cerebellar artery territory brachium pontis infarcts of probable hemodynamic cause. Eur Neurol (2004) 0.75

Hemihyperplasia-multiple lipomatosis syndrome (HHML): a challenge in spinal care. Acta Orthop Belg (2008) 0.75

The Saxon Epilepsy Center Kleinwachau, Radeberg, Germany. Epilepsy Behav (2017) 0.75

Cell-based assays to probe the ERK MAP kinase pathway in endothelial cells. Methods Mol Biol (2009) 0.75

Conformal and highly luminescent monolayers of Alq3 prepared by gas-phase molecular layer deposition. ACS Appl Mater Interfaces (2013) 0.75

Response of halogenated compounds in ion mobility spectrometry depending on their structural features. Talanta (2010) 0.75

Surface, interface and bulk electronic and chemical properties of complete perovskite solar cells: Tapered cross-section photoelectron spectroscopy a novel solution. ACS Appl Mater Interfaces (2020) 0.75

Massive four-territories stroke: bilateral middle and anterior cerebral artery infarctions. Eur Neurol (2002) 0.75